Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction

This publication has 21 references indexed in Scilit:

• Preliminary experience with a high bolus dose of tirofiban during percutaneous coronary intervention
  Current Medical Research and Opinion, 2003
• Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes
  Circulation, 2002
• Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)
  The American Journal of Cardiology, 2002
• Platelet inhibition with tirofiban early during percutaneous coronary intervention: Dosing revisited
  Catheterization and Cardiovascular Interventions, 2002
• Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors
  Catheterization and Cardiovascular Interventions, 2001
• Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention
  Circulation, 2001
• Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement
  Heart, 2001
• Platelet Glycoprotein IIb/IIIa Antagonists
  Circulation, 1999
• Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention
  The American Journal of Cardiology, 1995
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994